Efficacy and safety of infliximab versus adalimumab in the therapy of fistulizing Crohn disease: a systematic review and indirect comparison [report]

Wu Guozhi
2020 unpublished
doi:10.37766/inplasy2020.4.0089 fatcat:o6gj36uuzvagxigwiliktk5yiq